Marketing Deep Dive
From Attribution to Activation
Attract higher-value patients. Convert them more often. Watch your acquisition cost drop.
We capture true marketing qualified leads across calls, forms, online scheduling, text, and chat. Then feed them back to your ad platforms, CRM, and PMS/EHR automatically, reducing patient acquisition cost by 15-25%.
The Activation Loop
Live Attribution Feed
Near real-time · All Platforms
2s ago
14s ago
1m ago
3m ago
Best in Class Marketing Efficiency
Most platforms optimize on clicks or call duration. Patient Prism Segments identify the highest-LTV patients from every conversation across every channel, then activate that intelligence back into your marketing stack so your spend finds the patients that matter most.
Mommy Makeover Candidate
- 84 Qualified Leads / Mo
- 38% Conversion Lift
- $142 CPA Segmented
- $12,400 Average Patient LTV
Full Arch Implant Candidate
- 127 Qualified Leads / Mo
- +44% Conversion Lift
- $96 CPA Segmented
- $28,500 Average Patient LTV
Premium Injectable Client
- 203 Qualified Leads / Mo
- 31% Conversion Lift
- $68 CPA Segmented
- $4,800 Average Patient LTV
Closed-Loop Marketing Activation
Connect every ad dollar to a booked appointment, and every booked appointment back to the campaign and bidding algorithm that drove it.
Patient Prism automates the full activation loop between your front desk, your marketing platforms, and your growth strategy.
Marketing Source Captured
Dynamic number insertion and UTM deep-matching track the specific
campaign, keyword, and visitor session across every channel.
| Source | Campaign | Channel | GCLID |
|---|---|---|---|
| Google Ads | Rhinoplasty_Spring_MIA | Inbound Call | CjwKCAjw… |
Frequently Asked Questions
Same-store Growth. No New Marketing Spend.
EBITDA You Can Model
Healthcare networks using Patient Prism recover 20-30% of lost revenue from opportunities already in your existing lead flow.
No new campaigns, no new hires – that’s profitable growth.
The revenue is already there. You’re just not capturing it yet.